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Combat-related posttraumatic stress disorder (PTSD) is common among returning 
veterans, and is a serious and debilitating disorder. While highly effective treatments 
involving trauma exposure exist, difficulties with engagement and early drop may lead 
to sub-optimal outcomes. Mindfulness training may provide a method for increasing 
emotional regulation skills that may improve engagement in trauma-focused therapy. 
Here, we examine potential neural correlates of mindfulness training and in vivo expo-
sure (non-trauma focused) using a novel group therapy [mindfulness-based exposure 
therapy (MBET)] in Afghanistan (OEF) or Iraq (OIF) combat veterans with PTSD. OEF/OIF 
combat veterans with PTSD (N = 23) were treated with MBET (N = 14) or a comparison 
group therapy [Present-centered group therapy (PCGT), N = 9]. PTSD symptoms were 
assessed at pre- and post-therapy with Clinician Administered PTSD scale. Functional 
neuroimaging (3-T fMRI) before and after therapy examined responses to emotional 
faces (angry, fearful, and neutral faces). Patients treated with MBET had reduced PTSD 
symptoms (effect size d =  0.92) but effect was not significantly different from PCGT 
(d = 0.43). Improvement in PTSD symptoms from pre- to post-treatment in both treat-
ment groups was correlated with increased activity in rostral anterior cingulate cortex, 
dorsal medial prefrontal cortex (mPFC), and left amygdala. The MBET group showed 
greater increases in amygdala and fusiform gyrus responses to Angry faces, as well as 
increased response in left mPFC to Fearful faces. These preliminary findings provide 
intriguing evidence that MBET group therapy for PTSD may lead to changes in neural 
processing of social–emotional threat related to symptom reduction.
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inTrODUcTiOn
Posttraumatic stress disorder (PTSD) affects up to ~20% of 
combat veterans returning from Afghanistan (OEF) and Iraq 
(OIF) (1), and is associated with high levels of suffering and 
disability. There is considerable empirical support for exposure-
based individual psychotherapy for PTSD involving processing 
of traumatic memories [e.g. prolonged exposure therapy (PE), 
cognitive processing therapy (CPT)] and these individual treat-
ments show very large effect sizes in military veterans compared 
to baseline (pre–post Cohen’s d in the 1.0–2.0 range) and often 
in comparison to active therapies (2, 3). However, even with the 
strong evidence of efficacy for exposure therapy, many veterans 
with PTSD do not fully engage in treatment and others drop-out 
prior to receiving full benefit (3, 4).
Group psychotherapy is a common modality in PTSD treat-
ment, in particular in the veterans affairs (VA) health system 
in the United States, and recent data suggest that they may be 
associated with better adherence and retention compared to 
individual therapies (5). It would appear that group therapies 
might provide a useful way to deliver non-trauma-focused self-
regulation, coping skills, and social skills, because they capitalize 
on patients’ collaborative support in a group environment and 
may be efficient. However, group therapies appear to be consid-
erably less effective than individual therapy for PTSD symptom 
reduction, even when the content of the intervention was similar 
[e.g., individual vs. group present-centered therapy (PCT), 
trauma-focused exposure therapy, CPT] (6–8). A meta-analysis 
of group therapy for PTSD reported an overall mean effect size of 
d = 0.56 in all populations (9), with lower efficacy in men and in 
particular, considerably lower efficacy in male combat veterans 
with PTSD (effect sizes ranging from 0.09 to 0.31). A recent large 
study of women veterans (N = 272) treated with group form of 
CPT that was not included in the meta-analysis found pre-post 
effect size estimate range of 0.27–0.38 (8).
Mindfulness-based interventions, such as mindfulness-based 
stress reduction (MBSR) and mindfulness-based cognitive 
therapy (MBCT), involve training in attention and emotional 
regulation (10, 11) and are delivered in group format. There is 
accumulating evidence that MBCT and MBSR may be helpful 
for depression, and anxiety: MBCT has demonstrated effective-
ness for relapse prevention in patients with severe, chronic major 
depressive disorder (12), and MBSR and MBCT appear useful for 
depression (13, 14) and generalized anxiety disorder (GAD) (15). 
Recent studies have suggested that mindfulness training may also 
be a useful component for treatment of PTSD. Improvement in 
depression and PTSD symptoms has been shown in pilot studies 
of MBSR in adults with childhood sexual abuse history (16, 17) 
and combat veterans (18, 19). We found that an 8-week MBCT 
specifically adapted for PTSD led to improvement in avoidant 
symptoms in chronic PTSD patients (Vietnam veterans) (20), and 
recent larger randomized controlled studies of MBSR adapted for 
combat PTSD in primarily Vietnam veterans have shown similar 
results (21).
We have been interested to examine whether mindfulness 
training together with non-trauma-focused in  vivo exposure 
may provide emotion regulation skills in a group modality 
that might lead to improvement in PTSD symptoms, as well as 
increased engagement and retention in subsequent individual 
trauma-focused therapy. We also wanted to examine whether 
mindfulness training in the context of in  vivo exposure might 
be associated with unique neural signatures. There has been 
considerable amount of neuroimaging research on the emotional 
neurocircuitry of PTSD [meta-analyzed in (22–25)], which has 
implicated increased activity in amygdala, insula, and mid- and 
dorsal anterior cingulate cortex (ACC) in trauma recall (e.g., 
trauma script-driven imagery, visual and auditory presenta-
tion of trauma-related cues), and non-trauma-related aversive 
social–emotional processing (visual presentation of fearful and 
angry emotional faces and aversive social scenes) and decreased 
activity in frontal lobe regions (e.g., ventral medial prefrontal 
cortex (mPFC), rostral ACC, and some regions of dorsal ACC) 
in trauma recall, non-trauma emotional stimuli, and emotional 
Stroop tasks in PTSD. However, there have been relatively few 
neuroimaging studies of PTSD psychotherapy. Studies of neural 
predictors of treatment outcome have reported better therapy 
responses associated with lower levels of pre-therapy amygdala 
and rostral ACC responses to rapidly presented fearful faces 
(26, 27) and higher dorsal striatal and frontal activations during 
inhibitory tasks (28). A small number of longitudinal (“pre–post” 
design) studies have reported changes in brain activations that 
differ between treatment responders and non-responders, includ-
ing ACC and insula activation on tasks involving anticipation of 
negative or positive images (29, 30) and Stroop task (31), as well 
as changes in left inferior parietal lobe (IPL) during contextual 
cue processing (32).
Several imaging studies have shown alterations in resting-state 
functional connectivity (rsFC) in long-term meditators (33–36). 
Similar effects on rsFC have also been reported in healthy persons 
and patients randomized to brief (6–8 week) group meditation 
trainings (37–41), and changes in interoceptive processes have 
also been reported (42, 43). A small number of neuroimaging 
studies of mindfulness training in anxiety disorder patients have 
found MBSR-related changes in self-related neural processing 
in social anxiety (44, 45), and dorsolateral PFC and amygdala–
frontal cortex connectivity in GAD (46) associated with symptom 
improvement, i.e., similar regions as implicated in improvement 
in PTSD symptoms. We recently conducted a pilot trial of a novel 
non-trauma-focused PTSD group intervention incorporating 
PTSD psycho-education, mindfulness training, and in vivo expo-
sure, “mindfulness-based exposure therapy” (MBET), compared 
to a manualized comparison group therapy, present-centered 
group therapy [PCGT, originally designed as a control for expo-
sure-based therapies (7, 47)]. The present study examines effects 
of MBET (which contains both mindfulness training and in vivo 
exposure) on neural correlates of PTSD symptom reduction, in a 
pre–post therapy fMRI study using a probe of social–emotional 
threat, presentation of faces with angry, fearful, and neutral 
expressions. Based on previous findings of decreased activity in 
mPFC/ACC during emotional tasks in PTSD patients (22–25), 
we hypothesized that improvement in PTSD symptoms would be 
associated with increased activity in medial frontal cortex when 
viewing faces with threatening emotional expressions. Given the 
mixed findings of altered amygdala activity during emotional 
TaBle 1 | Demographics.
characteristic MBeT (N = 14) PcgT (N = 9) t/χ2 p
Age, M (SD) 32.43 (7.54) 31.67 (10.14) 0.207 0.838
Race, N (%) 0.109 0.742
European American 13 (93%) 8 (89%)
African American 1 (7%) 1 (11%)
Education, N (%) 1.431 0.489
Some grad school or graduate degree 1 1
Some college or college degree 11 5
High school grad 2 3
CAPS, M (SD) 72.29 (18.32) 74.11 (15.34) 0.213 0.833
Comorbidities, N (%)
Mood disorder 13 (93%) 6 (67%) 2.616 0.106
Anxiety disorder 3 (21%) 1 (11%) 0.406 0.524
Substance use disorder 3 (21%) 0 2.218 0.136
Psychiatric medications
None 2 (14%) 3 (33%) 1.168 0.280
SSRI 4 (29%) 3 (33%) 0.059 0.809
Sleep 2 (14%) 2 (22%) 0.240 0.624
Benzodiazepine 2 (21%) 1 (11%) 0.406 0.524
Pain 2 (21%) 1 (11%) 0.406 0.524
Other 5 (36%) 2 (22%) 1.028 0.311
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processing in PTSD, we hypothesized changed activity in these 
regions.
MaTerials anD MeThODs
Methods
Participants
The study was approved by the Institutional Review Boards at the 
University of Michigan Medical School and the Ann Arbor VA. 
Written informed consent was obtained after a complete descrip-
tion of the study was provided to the participants. We recruited 
male OEF/OIF combat veterans with PTSD (N =  23) seeking 
treatment for PTSD at the VA Ann Arbor Health System (see 
Table 1). All individuals met DSM-IV criteria for current (past 
month) PTSD, as assessed by the Clinician Administered PTSD 
Scale (CAPS) (38). Participants were also assessed for comor-
bid disorders using the Mini-International Neuropsychiatric 
Interview (MINI) (39). Participants with psychosis, personality 
disorders, or suicidal risk were excluded. Psychiatric medications 
were allowed, but no changes in medications were allowed from 
4 weeks before the intake scan until the end of the interventions 
and post-intervention scan. No differences in presence of medi-
cations were observed between the treatment group (medications 
included SSRI: citalopram, fluoxetine, sertraline, venlafaxine; 
Sleep: trazadone, zolpidem; Pain: codeine, morphine, tramadol; 
Benzodiazepine: clonazepam, lorazepam; Other: aripiprazole, 
buproprion, prazocin, sumatriptan, topiramate).
Procedure
Participants underwent a functional magnetic resonance imaging 
(fMRI) scan within 2 weeks of the initial screening visit. Patients 
were randomized into one of two 16-week group therapy groups 
for PTSD: MBET or PCGT, each with two to six patients per 
group. However, randomization was only partial because the 
PCGT arm was discontinued during the trial due to higher drop-
out rate and recruitment difficulties. Within 2 weeks after the end 
of the interventions, participants underwent a second diagnostic 
interview and fMRI scan.
Therapists and Raters
Therapists were doctoral and masters-level psychologists at a VA 
PTSD clinic who had training in MBCT and in PCT. Trained, 
experienced clinical raters administered diagnostic clinical inter-
views (CAPS and MINI) and were blind to treatment condition.
Mindfulness-Based Exposure Therapy
This 16-week non-trauma-focused intervention was developed 
by the authors at the VA Ann Arbor, incorporating mindful-
ness training from MBCT, PTSD psycho-education and in vivo 
exposure from prolonged exposure therapy, and self-compassion 
exercises as we have recently described (48, 49). In vivo exposures 
were conducted only to avoided (and objectively safe) situations 
or activities. It was explicitly stated that no imaginal exposure 
or processing of trauma memories would be done in this group. 
The intervention consists of four “modules”: (a) PTSD psycho-
education and relaxation, (b) mindfulness of body and breath 
exercises and in vivo exposure, (c) mindfulness of emotion and 
in vivo exposure, and (d) self-compassion training. The group ses-
sions were 2 h each and participants completed daily homework 
in between sessions, involving formal and informal mindful-
ness practice and in vivo exposure, but no trauma exposure or 
processing.
Present-Centered Group Therapy
This therapy was initially developed by Schnurr et  al. (7) to 
represent all of the elements of effective PTSD treatment that are 
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not specifically trauma-focused. PCGT is a group intervention 
derived from and with the same content as an individual therapy 
(PCT) that has considerable efficacy for improvement in PTSD 
symptoms in military veterans (50). PCGT controls for non-
specific therapeutic factors such as group bonding and therapist 
support, as well as contact with therapists with specialized 
knowledge about PTSD. It focuses on identifying and discussing 
current life stressors that contribute to PTSD, group problem 
solving, psycho-education, and promotion of wellness and physi-
cal health. Similar to the MBET group, the intervention contains 
daily homework assignments, involving monitoring diaries of 
stressful situations and when PTSD symptoms cause impairment 
in social and occupational functioning, and also meets for 2 h a 
week for 16 weeks. It does not contain instructions on mindful-
ness, exposure, or cognitive restructuring.
MRI Scanning
At week 0–1 (prior to starting group therapy) and at weeks 17–18 
(after group termination), participants underwent both struc-
tural and functional MRI scanning. The functional MRI session 
included the emotional faces task reported here, a resting-state 
scan and a separate emotion regulation task in which aversive 
general social–emotional scenes [from the international affective 
picture set (“IAPS”)] were viewed (results reported separately). 
This paper reports results obtained from an emotional faces 
processing task. To control for potential order effects (“bleed 
over”), the order of tasks were counter balanced in a pseudo-
randomized manner. It should be noted that no “trauma-related” 
tasks (e.g., trauma script-driven imagery, Iraq, Afghanistan, or 
combat-related imagery tasks, etc.) were performed in this study. 
fMRI data are available from N =  23 PTSD patients reported 
here, out of a total of N = 38 who started one of the two group 
therapies. Patients in the initial therapy groups in the study were 
not scanned.
fMRI Data Acquisition and Analyses
All scanning was performed using a Philips 3-Tesla MRI scan-
ner (Phillips Medical Systems, Andover, MA, USA) in the fMRI 
laboratory at the Ann Arbor VA. A total of 240 T2*-weighted 
echo planar gradient-recall echo volumes were acquired during 
rest (echo time =  30  ms, repetition time =  2000  ms, 64 ×  64 
matrix, flip angle =  90°, field of view =  22  cm, 42 contiguous 
3  mm axial slices per volume). Five additional volumes were 
discarded at the beginning of each run to allow for equilibration 
of the MRI signal. A high-resolution T1-weighted structural 
image (3D turbo-fast-field-echo, 1  mm isotropic voxel, 2562 
matrix, 180 slices, repetition time = 9.8 ms, echo time = 4.6 ms, 
flip angle =  8°) was also obtained to provide for more precise 
anatomical localization. fMRI data were analyzed using the sta-
tistical parametric mapping software package, SPM8 (Wellcome 
Department of Cognitive Neurology, London, UK). Functional 
slices within each volume were sinc-interpolated, weighted in 
time, slice-by-slice, to correct for the sequence of slice acquisi-
tion. The functional volumes were realigned to correct for head 
motion and structural images coregistered to the mean of func-
tional images. The structural images were spatially normalized 
to a standard Montreal Neurological Institute (MNI) template 
using the voxel-based morphometry toolbox (VBM8; http://
dbm.neuro.uni-jena.de/vbm) and DARTEL high dimensional 
warping (51). Estimated deformation fields from warping were 
applied to normalize images to MNI space, and smoothed using 
an 8-mm FWHM Gaussian kernel. Functional data are detrended 
to account for scanner drift.
Experimental Paradigm
This paper reports results from a variant of an emotional faces 
matching task (52, 53). This task has previously been shown to 
reliably and robustly engage the amygdala and has been widely 
used to assess amygdala’s reactivity to social cues, and we have 
previously reported this task (54, 55). Participants viewed a trio 
of faces on the screen and were instructed to choose one of the 
two faces on the bottom that expressed the same emotion as the 
target face on top. The face photographs were selected from a 
validated stimulus set (56). The identities of the three faces were 
different and overall an equal number of male and female faces 
were presented. We studied target and congruent probe faces 
displaying one of three expressions (angry, fearful, or neutral); 
and the other (incongruent) probe faces always displayed a neu-
tral face (during emotional target blocks) or a pseudo random 
emotional face (during neutral target blocks). Equal numbers of 
angry and fearful faces were randomly presented across trials. 
Blocks of face-matching tasks were interspersed with blocks of a 
baseline task of matching geometric shapes (circles, rectangles, 
and triangles) with similar instructions as above to maintain 
attention and provide a non-emotion processing contrast. Three 
blocks of each emotional face were presented, interspersed with 
blocks of shapes; each block was presented for 20 s.
Data Analysis
Data were analyzed using the statistical parametric mapping 
software package, SPM8 (Welcome Department of Cognitive 
Neurology, London, UK). Functional volumes were slice time 
corrected to account for temporal differences in slice acquisition 
time, realigned to the 10th volume to correct for head motion, 
segmented into gray matter, white matter, and CSF using the 
voxel-based morphometry toolbox (VBM8) and spatially 
normalized to a standard template based on the MNI reference 
brain using DARTEL high dimensional warping, and spatially 
smoothed using a 6-mm FWHM Gaussian kernel. Single-subject 
analysis was performed using standard GLM analysis in SPM8. 
Models consisted of regressors for task conditions (angry, fearful, 
and neutral blocks) as well as nuisance regressors consisting of 
the motion correction parameters from the realignment preproc-
essing step. Contrasts of responses of each facial expression to 
shapes were generated for each subject, and then entered into a 
second-level general linear model treating subject as a random 
effect (random effects analysis). We utilized the analysis strategy 
used by multiple previous studies (52–57) to explore the potential 
specific signature effects of each of the threat faces (fearful and 
angry) as well as neutral faces separately contrasted to the shapes 
condition (angry > shapes, fearful > shapes, neutral > shapes). 
Our approach to model each facial expression (contrasted with 
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shapes) allows us to examine effects of treatment on each face 
type, and is less potentially ambiguous than using a contrast of 
emotional faces  >  neutral faces. Previous work has reported 
that “neutral” faces have robust amygdala responses (58–61) 
and amygdala responses to neutral expression faces appears to 
be moderate by both psychopathology (59) and facial “trait” 
characteristics (60, 61); and, thus, potential effects of symptoms 
and other moderators on both emotional and neutral faces could 
create ambiguity in interpreting emotional > neutral contrasts. 
Angry and fearful faces were also analyzed separately because of 
reports of different processing of angry and fearful threat cues 
(62), and because we are interested changes in neural responses to 
emotional faces over time (pre- to post-therapy). This approach 
represented a within-subjects, longitudinal repeated measures 
(pre- to post-therapy) design, in which each participant’s post-
therapy scan to each face expression type (angry, fearful, and 
neutral) was compared to their own baseline (pre-therapy) scan 
of the same contrast.
In our primary analyses, we aimed to identify brain regions 
in which responses to emotional faces changed from pre- to 
post-psychotherapy in association with improvement in PTSD 
symptoms. We first constructed within-subjects T-maps of the 
Post > Pre-therapy contrasts of emotional faces > shapes to iden-
tify therapy-associated changes in brain responses. We then used 
a regressor of change in total CAPS scores (“deltaCAPS” regres-
sor) in between-subjects regression analyses to identify brain 
activation changes that correlated with symptom change. A priori 
defined regions of interests (ROI) amygdala and mPFC/anterior 
cingulate were examined for differences in emotional activations, 
based on the published literature in PTSD neuroimaging (22–24, 
63). For our primary ROI analyses, small volume correction 
(SVC) with family-wide error (FWE) corrected p-value <  0.05 
was used. SVC masks were created using anatomical AAL atlas 
for bilateral amygdala, and mPFC. To explore direction of the 
changes contributing to the observed effects, signal changes were 
extracted from ROIs. Clusters of activation observed outside of 
a priori regions were reported as significant if they met whole-
brain FWE corrected p < 0.05.
To identify potential differential effects of the two psycho-
therapies (MBET and PCGT), we conducted exploratory analyses 
utilizing flexible repeated-measures ANOVA (RM-ANOVA) in 
spm8. In this intervention outcome study, we were specifically 
interested in group ×  time interactions characterized by group 
differences at post-intervention due to the experimental group 
increasing (or decreasing) over time, but no difference at pre-
intervention, and in which the control group does not change 
over time (known as “spreading” interactions, as opposed to 
“cross-over” interactions that could reflect pre-existing differ-
ences in groups at intake). To test for spreading interactions, we 
utilized the conjunction analysis of Friston and colleagues (64, 65) 
within flexible ANOVA F test maps to test the likelihood of voxels 
having a consistent main effect of time, group, and group × time 
interaction effect (each of which should exist in a consistent 
direction at a minimum threshold in a true spreading interaction, 
although each may not be individually significant) with search 
area restricted to areas where direction of all three effects agreed. 
The conjunction was performed on the F test maps for the three 
effects, with the search area being restricted to areas where the 
direction of all three effects agreed, p-values were adjusted for the 
a priori conditions of interest (i.e., all three signs consistent), and 
thresholded at p < 0.005.
To identify potential psychotherapy-associated changes in 
patterns of effective connectivity of brain regions associated 
with PTSD symptom improvement, we conducted exploratory 
analyses utilizing psychophysiological interaction (PPI) analysis. 
We performed PPI analyses of connectivity during processing of 
threat (angry faces) compared to baseline connectivity (during 
the shapes condition) in brain regions, associated with PTSD 
symptom changes. Regions with changes in activity that cor-
related with PTSD symptom improvement were used as “seed 
regions.” Seeds were 5-mm radius spheres centered around 
voxels showing peak correlation of post > pre-therapy T-maps 
with a delta CAPS regressor. De-convolved time series for each 
seed from each participant were multiplied by a block vector 
representing the contrast of interest (angry faces vs. shapes), and 
individual models contained regressors for the seed time series, 
the original conditions, and the interaction terms, and regres-
sors were convolved with the canonical HRF (66). Resulting 
contrast maps were entered into second-level random effects 
analyses (pre- vs. post-therapy paired t-tests) and thresholded 
at p < 0.005.
resUlTs
Participants
The two PTSD therapy groups did not significantly differ by PTSD 
symptom severity (CAPS scores), number of Axis I comorbidi-
ties, age, race, or medication use at intake (see Table 1).
effects of MBeT and PcgT group Therapy 
on PTsD symptoms
The participants in this fMRI study (N =  23) were a subset of 
a larger controlled trial comparing MBET and PCGT (N = 38). 
The overall outcomes in the entire sample, as well as details of 
study design, compliance and retention, and detailed descrip-
tion of the interventions, are reported separately (King et  al., 
unpublished data). Individual pre- and post-therapy total CAPS 
scores for patients in this sub-sample recruited for pre-post fMRI 
experiment and treated with each therapy are shown in Figure 1. 
MBET showed a significant reduction in total CAPS score [pre 
vs. post MBET t(13) = 3.29, p = 0.006, average 16 point decrease 
in total CAPS, effect size d = 0.92, effect size as per Ref. (67) Eq. 
8]. PCGT was associated with a smaller decrease [pre vs. post 
PCGT t(8) = 1.81, p = 0.10, average 7.0 point decrease in total 
CAPS, d =  0.43]. In between condition analyses, RM-ANOVA 
condition ×  time interaction were not significant for pre–post 
analyses [F(1,20) =  1.62, p =  0.22] in total CAPS scores. The 
between condition post-therapy CAPS score effect was d = 0.41. 
Patients in the MBET group attended more group therapy ses-
sions than patients treated with PCGT [average of 13.5 vs. 8.5 
sessions, respectively, t(19) = 5.39, p < 0.001].
TaBle 2 | changes in brain responses to emotional faces from pre- to post-therapy that correlate with improvement in PTsD symptoms (change in 
total caPs score).
Peak cluster
region x y z Z-score sVc pFWe ke sVc pFWe
angry > shape
Post > pre
Medial frontal gyrus (BA10)/rostral ACC (BA 32) −12 50 4 4.18 0.011 42 0.014
Medial frontal gyrus (BA9) −9 47 37 3.56 0.078 22 0.039
(BA10) −12 44 22 3.47 0.100
Left Amygdala/peri-amygdala −15 −1 −17 4.80 0.006 15 0.019
Fearful > shape
Post > pre
No significant clusters
neutral > shape
Post > pre
No significant clusters
Italics: peak of a subcluster.
FigUre 1 | changes in PTsD symptoms in response to group therapy 
in the patients with fMri scans in this study. Shown are PTSD 
symptoms (total CAPS scores) before and after a 16-week group therapy 
with (a) mindfulness-based exposure therapy (MBET, N = 13 pre–post) and 
(B) present-centered group therapy (PCGT, N = 8 pre-post). Patients who 
experienced a clinically significant improvement in PTSD (change in CAPS 
>10 points from pre–post treatment) are shown in solid lines, patients who 
did not have clinically significant improvement shown in dashed lines.
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changes in Brain responses to emotional 
Faces Pre- to Post-Therapy that correlate 
with improvement in PTsD symptoms
Imaging data from two participants (one in MBET, one in PCGT 
condition) were excluded from the following analyses due to 
technical problems with data acquisition that made the data 
unusable. As could be expected, the emotional faces (fearful, 
angry, and neutral) evoked robust activations of visual cortex, 
dorsal medial frontal gyrus/SMA, bilateral inferior frontal gyrus, 
and bilateral amygdala, and de-activations of “task-negative” 
regions posterior cingulate and ventral medial PFC (data not 
shown). To test for potential order or “spill-over” effects of tasks 
(which were counter balanced), we examined amygdala responses 
in patients who had IAPS pictures or faces tasks completed first. 
No differences in amygdala reactions to neutral, angry, or fearful 
faces were observed. To identify brain changes associated with 
improvement in PTSD symptoms, we first searched for clusters 
of brain activations whose change from pre- to post-therapy was 
correlated with improvement in total PTSD symptoms (using a 
delta CAPS regressor). To maximize our power in this pilot study, 
we first conducted regression analyses in the total sample of 
PTSD patients (i.e., treated with either MBET or PCGT, N = 21) 
to identify brain regions associated with improvement in PTSD 
symptoms associated with either therapy. Significant clusters of 
correlation with PTSD symptom changes are shown in Table 2 
(hypothesized regions reported as significant after SVC FWE cor-
rected p-value <0.05, clusters outside of a priori regions reported 
as significant if they met whole-brain FWE corrected p < 0.05). 
Positive correlations of increased brain responses to angry faces 
with PTSD symptom improvement from pre- to post-therapy 
were identified in two regions in medial frontal cortex: a cluster 
spanning mPFC (BA10) and rostral ACC (BA32, Figure 2A), and 
a more dorsal region of medial frontal cortex spanning BA9 and 
BA10 (Figure 2A), and left peri-amygdala area (Figure 2B). To 
visualize the distribution of improvement in PTSD vs. change in 
activations in ROIs, scatter plots are shown in Figure 2C. dmPFC 
BA9, Figure 2D, rmPFC BA10/BA32, and Figure 2E, left peri-
amygdala from pre- to post-therapy. All images represented in 
neurological convention, i.e., left side of the image corresponds to 
the left side of the brain. Colors of clusters represent “heat map” 
of Z-scores, see scale to right of images. No significant clusters of 
negative correlation were seen with the same contrast (i.e., brain 
responses that decreased from pre- to post-therapy correlated 
with PTSD symptom improvement). No significant positive or 
negative correlations of delta CAPS regressor with pre- to post-
therapy changes in brain responses to fearful or neutral faces were 
detected.
Differential changes in responses to 
emotional Faces Pre- to Post-Therapy 
with MBeT vs. PcgT
To identify potential differential effects of therapies (MBET vs. 
PCGT) in evoking changes in brain responses to emotional faces 
related to changes in PTSD symptoms (e.g., changes in amygdala 
FigUre 2 | correlations of changes in brain responses to angry faces to improvement in PTsD symptoms pre- to post-group therapy. Post-
therapy > pre-therapy Z-maps of brain activations to angry faces were regressed with improvement in PTSD symptoms (change in CAPS scores) in whole-brain 
voxel-wise analyses (visualized at p < 0.001, uncorrected). (a) Saggital section (x = −12) showing dorsal medial PFC BA9 peak (−12, 44, 22) and medial PFC 
BA10/BA32 peak (−12, 50, 4) correlation clusters. (B) Coronal section (y = −1) showing left amygdala/peri-amygdala correlation cluster [peak (−15, −1, −17)]. 
(c–e) Scatter plots are shown to visualize distribution of improvement in PTSD vs. change in activations (betas from ROI, arbitrary units) in (c) dmPFC BA9, (D) 
rmPFC BA10/BA32, and (e) left peri-amygdala from pre- to post-therapy. Filled circles are beta values from PTSD patients treated with MBET, open circles patients 
treated with PCGT. (Colors of clusters represent “heat map” of Z-scores, see scale to right of images. All images represented in neurological convention, i.e., left side 
of the image corresponds to the left side of the brain).
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and medial frontal cortex responses), we used a whole-brain 
RM-ANOVA approach test group (MBET vs. PCGT) by time 
(pre- vs. post-therapy) interaction effects, utilizing a “spreading 
interaction” contrast (as described in Methods). Differential 
changes in brain activations to angry, fearful, and neutral faces 
are listed in Table 3 (group × time spreading interaction term). 
Treatment-specific changes in response to angry faces were 
observed in left amygdala, characterized by increased left amyg-
dala responses in patients treated with MBET, but not in patients 
treated with PCGT (Figure 3A). Treatment-specific changes were 
also seen in right fusiform gyrus (Figure 3B) and left parahip-
pocampal gyrus, as well as left precuneus, and posterior cingulate 
(Table 3). In responses to fearful faces, an increase in activity in 
an area of medial frontal cortex/BA10 was seen in MBET but not 
in PCGT (Table 3, Figure 3C.). In responses to neutral faces, a 
similar increase in response to in fusiform gyrus was seen in the 
MBET group only (Table 3).
changes in Pre- to Post-Therapy effective 
connectivity Viewing angry Faces in Brain 
regions associated with PTsD symptom 
improvement
Psychophysiological interaction analyses were used to identify 
potential changes from pre- to post-therapy in effective con-
nectivity with the brain regions that were associated with 
PTSD improvement. Time series of activity of the left amygdala 
(−15, −1, −17) and left mPFC (−12, 50, 4) peaks of correlation 
with symptom improvement were used as seeds in PPI compar-
ing viewing angry faces to baseline (viewing shapes). Table  4 
shows results of changes in effective connectivity, from pre- to 
post-therapy Clusters of increases in effective connectivity to 
the left amygdala seed while viewing angry faces were seen in 
medial frontal gyrus (BA6)/dorsal ACC (BA 32, Figure  4A), 
lingual gyrus (Figure  4B), and left precentral gyrus following 
psychotherapy. Increased amygdala connectivity in these regions 
was not correlated with improvement in PTSD symptoms. No 
significant clusters were observed with the left mPFC seed.
DiscUssiOn
We examined neural correlates of treatment improvement in 
PTSD symptoms before and after 16 weeks of MBET/PCGT group 
psychotherapy for PTSD in OEF/OIF veterans. We examined 
changes in brain responses to social–emotional cues (viewing 
“threat-related” faces with angry or fearful expressions) before 
and after two forms of group psychotherapy, a novel mindfulness-
based group (MBET) and a comparison group therapy (PCGT). 
Improvement in PTSD symptoms irrespective of the type of group 
therapy was associated with increased responses in to angry faces 
from Pre- to Post-therapy in rostral medial PFC/peri-genual 
ACC (BA10/BA32); rostral/dorsal medial PFC (BA9/BA10), and 
left amygdala. The observed correlations in medial frontal cortex 
and amygdala activity likely reflect general improvement in PTSD 
TaBle 3 | Differential changes in responses to emotional faces pre- to 
post-therapy with MBeT vs. PcgT (rM-anOVa spreading interaction 
term p < 0.005).
region x y z F k
angry faces
Clusters within search area
L amygdala −15 2 −17 10.65 16
R parahippocampus 21 −10 −20 21.43 25
Other clusters
R fusiform/lingual gyrus 27 −67 −8 20.80 36
R precuneus 21 −64 55 18.11 202
18 −58 48 15.75
Posterior cingulate 0 −46 40 10.76 15
Fearful faces
Clusters within search area
L medial frontal gyrus (BA10) −12 62 13 17.19 16
Other clusters
None
neutral faces
Clusters within search area
None
Other clusters
R fusiform/lingual gyrus 24 −76 −8 20.80 71
30 −68 −8 11.90
L lingual gyrus −33 −78 16 12.27 73
L fusiform/lingual gyrus −18 −70 −11 11.28 30
L caudate body −18 −1 −13 11.12 36
Italics: peak of a subcluster.
FigUre 3 | Differential effects of MBeT vs. PcgT on changes in responses to emotional faces from pre- to post-therapy (rM-anOVa, group × time 
“spreading interaction”). (a) Group × time interactions in left amygdala (−15, 2, −17) in the viewing Angry Faces condition. (B) Group × time interactions in right 
lingual gyrus/fusiform gyrus (27, −67, −8) viewing Angry Faces. (c) Group × time interactions in left medial frontal gyrus (−12, 62, 13) viewing Fearful Faces.
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symptoms, independent of type of therapy or treatment. We also 
detected evidence for potential differences in neural responses to 
the two treatments in the overlapping brain regions: MBET was 
associated with greater increases in amygdala and lingual/fusi-
form gyrus responses to angry faces, and an increase in medial 
PFC responses to fearful faces (group × time interactions).
While group psychotherapies for combat PTSD in military 
veterans are common in some institutions (e.g., VA hospital 
PTSD clinics in the USA), and even though group therapy for 
PTSD appears to be associated with good retention and engage-
ment in VA settings (5), most reports to date have shown only 
weak efficacy for improving PTSD symptoms in military veterans 
and, in particular, male combat veterans (6, 7, 9). Thus, while 
this was a small pilot study that was primarily focused on neural 
correlates of group therapy for PTSD, the relatively robust effect 
size in the MBET condition (d =  0.92) suggests further study 
may be warranted in this modality. These findings complement 
other very recent studies involving group therapies for PTSD 
that have shown higher levels of efficacy [e.g., a controlled pilot 
study of group CPT in active duty military personnel (47) and 
an uncontrolled pilot study of group in  vivo exposure coupled 
with individual imaginal trauma exposure in military veterans 
(68)] to suggest that some group modalities may be efficacious 
for military populations with PTSD. The comparison interven-
tion used in this study (PCGT) is a group version of individual 
PCT that originally developed as a comparison therapy for RCTs 
of exposure-based PTSD therapy to control for “non-specific” 
FigUre 4 | increased left amygdala connectivity viewing angry faces 
following group psychotherapy. (a) Increased left amygdala connectivity 
with SMA/dorsal ACC. (B) Increased left amygdala connectivity with lingual 
gyrus.
TaBle 4 | changes from pre- to post-therapy in effective connectivity 
viewing angry faces in brain regions associated with PTsD symptom 
improvement (p < 0.001 uncorrected).
seed/region x y z Z-score K
l amygdala seed (−15, −1, −17)
L lingual/fusiform gyrus −15 −76 −2 3.98 36
−6 −94 −5 3.98
L precentral gyrus −39 −7 52 3.55 25
Medial frontal gyrus (BA6)/cingulate 
gyrus (BA32)
9 8 52 3.32 20
l mPFc seed (−12, 50, 4)
No significant clusters
Italics: peak of a subcluster.
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therapy factors. Interestingly, although it was thought of as a 
“non-specific control,” PCT in the individual format has shown 
considerable efficacy for PTSD improvement, and in a recent 
meta-analysis PCT was as efficacious as exposure therapy in three 
out of five studies (50), with “large” effect sizes 0.77–1.27. The 
group form of PCT (PCGT) used here was similarly developed 
as a “non-specific control” for an RCT comparison to a trauma-
focused group therapy (TFGT). While PCGT has shown consid-
erably lower efficacy for PTSD than individual PCT, it should be 
noted that PCGT had the same effect size as TFGT (7). Versions 
of PCGT (adapted to be the same number of sessions as the 
“active” group) have also been used as a comparison intervention 
in recent studies of group CPT for active duty military (47) and 
as a comparison group MBSR in veterans with PTSD (21). Thus, 
although only a “medium” effect size was seen for PCGT here, it 
is “on par” with multiple previous reports of both trauma-focused 
and non-trauma-focused group therapies for PTSD in military 
veterans (7, 9, 21).
Presentation of human faces with “threat-related” emotional 
expressions have been used in a number of neuroimaging studies 
of psychiatric disorders, including PTSD; fearful faces have been 
proposed to represent indirect or ambiguous threat, and angry 
faces a more direct or non-ambiguous threat (69). A number of 
PTSD neuroimaging studies have used emotional/“threat-related” 
faces, as well as other cognitive-emotional tasks, and symptom-
provocation (e.g., trauma scripts or trauma-related stimuli) [see 
meta-analyses (22–25)]. The most consistent findings in PTSD 
meta-analyses have been hyper-activity in mid-cingulate/dorsal 
ACC, insula, and amygdala, and hypo-activity in ventral medial 
PFC, rostral ACC, and dorsal mPFC. In the present study, we found 
that patients with the greatest improvement in PTSD symptoms 
following therapy showed greatest increases in regions of dorsal 
PFC BA9/BA10 previously associated with hypo-activation in 
PTSD. The medial PFC and rostral ACC are involved in a number 
of emotional regulatory processes, including effortful emotional 
regulation and fear extinction processes (70–73); and, thus, the 
observed increased activity in these regions is consistent with the 
notion that therapy-associated improvement in PTSD may be 
related to normalization of neural responses to social–emotional 
threat and improved emotional regulation.
However, our finding of PTSD-improvement-related increases 
in left amygdala activity might seem counter-intuitive in light of 
reports of hyper-activation of amygdala in PTSD. Exaggerated 
amygdala responses to threat-related emotional faces (e.g., fearful 
or angry faces) in PTSD have usually been found in studies using 
brief (200 ms) or backwards-masked presentation (<20 ms) of 
threat-related faces (26, 74–76); and, thus, reflect the early, rela-
tively automatic processing of faces and related amygdala activity. 
However, a number of studies with longer stimulus presentation 
have not reported exaggerated amygdala responses to threatening 
stimuli in PTSD (77–80); and, furthermore, a study of explicitly 
presented or “unmasked” fearful faces reported a negative, rather 
than a positive, correlation of amygdala responses with PTSD 
symptoms (75).
It was furthermore interesting that changes in amygdala 
responses related to PTSD symptom improvements were found 
in angry faces, but not in fearful faces, which as described above 
have been used in several previous neuroimaging studies of PTSD 
(26, 74–76), or in neutral faces. It is of course possible that the 
lack of detection is due to the relatively small N of this pilot study. 
However, differences in fearful vs. angry facial processing has 
been reported in previous studies (54, 62), suggesting the intrigu-
ing possibility that changes in processing of angry faces (overt 
social threat) might reflect specific changes in PTSD symptoms 
occurring over the course of treatment. We previously reported 
an effect of childhood poverty on connectivity of amygdala with 
medial frontal cortex in angry faces but not fearful faces (54). 
Furthermore, a recent EEG study of threat-related faces in OEF/
OIF combat veterans with and without PTSD (using a similar 
emotional face-matching task) similarly reported that veterans 
with PTSD “blunted processing” (smaller late positive potentials) 
and decreased accuracy in identifying angry faces but not fearful 
faces (81). It was proposed that PTSD may be associated with 
diminished processing of overt social threat in conjunction with 
impaired perception for angry faces specifically. Such reduced 
processing could represent a defensive or dissociative response 
that could be related to avoidant and numbing symptoms, and 
difficulty in engaging emotionally with trauma- or threat-related 
material in PTSD (82). If this is indeed the case, it is possible that 
the increased amygdala activity we observed to longer (3000 ms) 
processing of angry faces correlated to increased PTSD symptom 
reduction might reflect greater engagement and less avoidance 
of threat-related cues, and, thus, greater emotional processing of 
these cues. Indeed, PTSD patients who are successfully treated 
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may be better able to separate true threat and, thus, react more 
robustly when confronted with actually threatening stimuli in 
the environment. This is also supported by the finding of greater 
post-therapy amygdala connectivity with visual processing areas, 
including lingual gyrus and fusiform gyrus, involved in visual 
processing of faces, although these changes in connectivity were 
not correlated with PTSD symptom reduction.
While the observed increased medial PFC and amygdala 
responses may reflect general symptom improvement, we 
also found evidence of potential specific effects of MBET. 
Group  ×  time interactions found MBET was associated with 
greater post-therapy responses of both amygdala and fusiform/
lingual gyrus to angry faces, as well as greater activation of a 
region of left medial PFC in response to fearful faces, suggest-
ing that mindfulness-training may be associated with greater 
engagement with threat cues in PTSD patients. This would be 
consistent with the orientation of exposure, which involves 
engaging and “facing” feared stimuli, as well as mindfulness 
training, which involves engaging and observing both sensory 
phenomena and one’s emotional reactions to them in a balanced 
and accepting attitude, as opposed to either distraction/avoid-
ance or suppression of emotional responses. A recent pre–post 
therapy fMRI study with angry and neutral faces with patients 
with GAD comparing MBSR to an active control found greater 
activation in ventrolateral PFC following MBSR (46), as well as 
a shift from negative to positive amygdala functional connectiv-
ity with medial cortex and rostral ACC regions similar to those 
seen correlated with PTSD symptom improvement in the present 
study. Interestingly, they also found increased activity in occipital 
lobe regions associated with visual processing of faces. Similar to 
our interpretation, the authors suggested that the positive amyg-
dala–mPFC connectivity following MBSR in GAD may be due 
to greater neural processing of threat-related faces and engage-
ment. It should be noted that MBET includes in vivo exposure 
as well as mindfulness training and, thus, either or both of these 
components could be contributing to the observed effects in this 
small pilot. In future, larger studies we plan to directly compare 
the effects of separate groups involving mindfulness training and 
in vivo exposure. Furthermore, we found an intriguing sugges-
tion of a potentially unique neural signature in MBET: increased 
responses to fearful faces in a region of left OFC/medial frontal 
cortex was found in the MBET group only. In measures of rsFC 
in the same PTSD treatment study, MBET was also associated 
with an increase in positive rsFC of PCC with a similar region of 
left DLPFC (49), a pattern similar to that previously reported in 
long-term meditators (33), which has been proposed to reflect 
potential effects of mindfulness on volitional attention shifting 
and rumination. The findings presented here further implicate 
a potential effect of mindfulness-based interventions on PFC 
when processing threat, which may be involved in the salutary 
effects of mindfulness. In future studies we hope to identify and 
further elucidate the potential relationships between effects of 
mindfulness training as well as in  vivo (non-trauma) exposure 
on symptom reduction, social threat processing, attention, and 
rumination in PTSD.
We also used PPI to conduct exploratory whole-brain analyses 
of potential changes in connectivity from pre- to post-therapy in 
those regions in which we observed PTSD improvement-related 
changes in the strength of responses to angry faces. Changes in 
connectivity from pre- to post-therapy were not detected in the 
mPFC/rACC seed, but increased post-therapy connectivity to the 
left amygdala seed was detected in medial frontal gyrus/dorsal 
ACC and lingual gyrus. While these exploratory findings should 
be considered preliminary, they suggest greater connectivity of 
amygdala with both visual processing and potential emotional 
regulatory circuits after treatment; this is again consistent with 
the notion of greater engagement and perceptual and emotional 
processing of overt social threat following treatment. However, it 
should be noted a significant correlation was not detected between 
symptom improvement and the observed changes in amygdala 
connectivity. In future work, we plan to follow up in larger 
samples potential mindfulness- and exposure treatment-related 
changes in amygdala connectivity while processing social–emo-
tional threat, and the relationship to symptom changes.
limitations
This pilot pre- to post-therapy neuroimaging study of a novel 
therapy (MBET) is limited by the small number of PTSD patients 
with analyzable data (total N =  21), in particular in the PCGT 
group (N = 8). The discontinuation of the PCGT group decreased 
the number of patients available in the PCGT condition, thus 
decreasing power to detect potential effects of PCGT per se, and 
compare effects between the groups. However, the MBET group 
was reasonably powered for within-subjects analyses, given that a 
reliable effect size on PTSD symptoms was observed. We did not 
observe a statistically significant difference in pre-post effects of 
MBET and PCGT on PTSD symptoms in this small sample. While 
the degree of symptom reduction compared favorably with other 
studies of group psychotherapy for PTSD in military veterans, 
it was considerably smaller than effects reported for individual 
trauma-focused treatments (3), and the majority of patients in this 
study retained PTSD diagnosis following treatment. Thus, the pre-
sent brain activation findings may not be generalizable to patients 
who achieve remission from PTSD, which could be associated with 
additional changes in brain function. The therapists in this study 
were not blind to the study hypotheses. While we found evidence 
of differential brain activation effects between MBET and PCGT, 
since the “dose” of therapy was different between the groups we 
are limited in making causal inferences regarding whether these 
are related to the different therapeutic modalities employed in the 
groups (e.g., mindfulness training and in vivo exposure).
summary
This pilot study of a novel mindfulness-based, group in  vivo 
exposure therapy for combat PTSD (MBET) found improvement 
in PTSD symptoms from pre- to post treatment was associated 
with changes in brain responses to processing of angry faces, 
including increased activity in rostral and dorsal medial PFC, 
and left amygdala. While N was small for both groups, similar 
relationships were evident in both groups, suggesting that these 
may be a general effect related to PTSD symptom reduction. We 
also found evidence suggesting that the MBET group was associ-
ated with greater increases in amygdala and fusiform gyrus while 
processing angry faces, as well as greater increase in an area in left 
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medial PFC when processing fearful faces, and exploratory evi-
dence for potential treatment-related changes in amygdala con-
nectivity. While these must be considered preliminary findings 
given the sample size, they provide intriguing evidence that group 
therapy for PTSD may produce changes in neural processing of 
social–emotional threat that are related to symptom reduction.
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